TrialThe New England journal of medicine2026
Sacituzumab Tirumotecan in EGFR-TKI-Resistant,
Wenfeng Fang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this paperpooled ittrialcites it
TrialThe New England journal of medicine2026
Wenfeng Fang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.